AI Search Summary
This video explains the FDA approval of Opill, the first over-the-counter birth control pill in the United States, and summarizes what makes it different from combination oral contraceptives.
- Main question: What should people know about the FDA-approved over-the-counter birth control pill Opill?
- Short answer / core takeaway: Opill is a progestin-only oral contraceptive that had already been available by prescription for decades; the FDA advisory panel unanimously supported over-the-counter access after reviewing safety and labeling concerns.
- Evidence type: FDA advisory review, contraceptive effectiveness data, public-health access context.
- Search topics: Opill, over-the-counter birth control, FDA approval, progestin-only pill, mini-pill, oral contraception.
Common Search Questions
What is Opill?
Opill is a progestin-only birth control pill, sometimes called a mini-pill. Unlike many combination pills, it does not contain estrogen.
Why did the FDA allow Opill to be sold over the counter?
A panel of 17 independent FDA scientific advisors reviewed safety concerns and voted unanimously that the benefits outweighed the potential risks for over-the-counter access.
How effective is Opill with typical use?
The video states that the over-the-counter pill is identical to the prescription version and is about 93% effective at preventing pregnancy with typical use.
Who should avoid Opill according to the label concerns discussed?
The video highlights the label instruction to take it at the same time every day and not take it if you have breast cancer or are at high risk for breast cancer.
Key Takeaways
- Opill was the first birth control pill approved for over-the-counter sale in the United States.
- It was not a new medication; the prescription version had been on the market since 1973.
- Opill is progestin-only, which gives it a different safety profile from combination pills that also contain estrogen.
- The video frames the biggest practical caveats as correct daily use, label comprehension, breast-cancer risk warnings, and price/availability.
Transcript
FDA approval and basic context
The FDA just approved the first ever over-the-counter birth control pill, called Opill. Here’s what you need to know.
Opal. I didn’t know those worked like that. Sounds expensive.
No, Opill. But this isn’t some new drug. It’s been on the market for prescription use since 1973.
Why the advisory panel supported it
This past May, a panel of 17 independent scientific advisors to the FDA met to weigh all the potential safety concerns, and they voted unanimously that the benefits outweigh the potential risks.
Basically, the label says to take it at the same time every day and not take it if you have or are at high risk for breast cancer. And there’s no potential for abuse. No matter how hard you try, Opill won’t get you high.
Mini-pill versus combination pills
It’s known as a mini-pill because it only contains a single hormone, progestin, as opposed to combination pills, which also contain estrogen and have somewhat more safety concerns.
Effectiveness and availability
The over-the-counter pill will be identical to the prescription version, which is 93% effective at preventing pregnancy with typical use. Put another way, when 883 women used it for four years, only six got pregnant.
That’s better than any current over-the-counter contraceptive, including condoms. But it’s not available yet. The Dublin-based manufacturer has said that it’ll be available in stores and online in early 2024. But still no word on price.
Additional Notes
Caption context
The caption frames the video around the anxiety people may feel when focusing on the remaining risk after hearing a 93% typical-use effectiveness figure.
Keywords and topics
- Birth control access
- Over-the-counter contraception
- Progestin-only pill
- FDA drug approval